MEET LIFE SCIENCES LIMITED - Profile & Financials

Accounts Submitted 11 Aug 2025

Confirmation Statement Submitted 14 Aug 2025

Net assets £3.40M £850.29K 2024 year on year

Total assets £11.74M £2.09M 2024 year on year

Total Liabilities £8.35M £2.94M 2024 year on year

Charges 2

1 outstanding 1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Irongate House 30 Dukes Place London EC3A 7HX United Kingdom

Office (London)

Irongate House, 22 - 30 Dukes Pl, London EC3A 7LP

Office (Berlin)

Design Offices, Leipziger Platz 16, 10117 Berlin

Office (New York)

408 Broadway, Floor 4, New York, NY 10013

Office (San Francisco)

425 California Street, San Francisco, CA 94104

Office (San Diego)

1420 Kettner Blvd, Suite 100, San Diego, CA 92101

Telephone

+16282251200

ben.chitty@peoplewithchemistry.com

Website

peoplewithchemistry.com

Credit Report

Discover MEET LIFE SCIENCES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£1.25M

Increased by £123.61k (+11%)

Net Assets

£3.40M

Decreased by £850.29k (-20%)

Total Liabilities

£8.35M

Increased by £2.94M (+54%)

Turnover

£19.88M

Decreased by £408.44k (-2%)

Employees

Decreased by 13 (-18%)

Debt Ratio

71%

Increased by 15 (+27%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

3 Allotments 972 Shares £2k Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
31 Dec 2013	ORDINARY	48	£480	£10
31 Dec 2011	ORDINARY	24	£240	£10
30 Jun 2010	ORDINARY	900	£900	£1

Officers

3 active 5 resigned

Show resigned officers

						Status
Chris Haynes	Secretary	Unknown	Unknown	—	14 May 2025	Active
Chris John Latimer Haynes	Director	British	England	56	30 Apr 2025	Active
Hannah Margaret Haigh	Director	British	England	42	11 Nov 2014	Active

Shareholders

Shareholders (1)


Meet Life Sciences Group Limited	100.0%	1,250	Ordinary	14 Aug 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Meet Group Limited

United Kingdom

Active

Notified 30 Aug 2019

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Paul John Mcguire

Ceased 30 Aug 2019

Ceased

See All Controllers

Group Structure

MEET LIFE SCIENCES GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROJECT PANDA BIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

PROJECT PANDA TOPCO LIMITED united kingdom significant influence or control

NORTHEDGE CAPITAL III GP LLP united kingdom voting rights 25 to 50 percent limited liability partnership, right to share surplus assets 25 to 50 percent limited liability partnership

NORTHEDGE CAPITAL LLP united kingdom

NORTHEDGE CAPITAL FOUNDER GP LIMITED united kingdom shares 75 to 100 percent

NORTHEDGE CAPITAL FUND I GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

NORTHEDGE CAPITAL CORPORATE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

MEET LIFE SCIENCES LIMITED Current Company

Charges

1 outstanding 1 satisfied

Documents

Company Filings

Date	Category	Description	Document
14 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-07-27 with updates	View(4 pages)
11 Aug 2025	Accounts	Annual accounts made up to 2024-12-31	View(31 pages)
20 May 2025	Change Of Name	Certificate Change Of Name Company	View(3 pages)
14 May 2025	Officers	Termination of Stephen Robert Herniman as director on 2025-05-14	View(1 page)
14 May 2025	Officers	Appointment of Chris Haynes as director on 2025-05-14	View(2 pages)